264 related articles for article (PubMed ID: 28696300)
1. Acetylcholine-producing NK cells attenuate CNS inflammation via modulation of infiltrating monocytes/macrophages.
Jiang W; Li D; Han R; Zhang C; Jin WN; Wood K; Liu Q; Shi FD; Hao J
Proc Natl Acad Sci U S A; 2017 Jul; 114(30):E6202-E6211. PubMed ID: 28696300
[TBL] [Abstract][Full Text] [Related]
2. Maturation of circulating Ly6C
Dagkonaki A; Papalambrou A; Avloniti M; Gkika A; Evangelidou M; Androutsou ME; Tselios T; Probert L
Front Immunol; 2022; 13():972003. PubMed ID: 36159850
[TBL] [Abstract][Full Text] [Related]
3. Comparative study of the expression of cholinergic system components in the CNS of experimental autoimmune encephalomyelitis mice: Acute vs remitting phase.
Di Pinto G; Di Bari M; Martin-Alvarez R; Sperduti S; Serrano-Acedo S; Gatta V; Tata AM; Mengod G
Eur J Neurosci; 2018 Sep; 48(5):2165-2181. PubMed ID: 30144326
[TBL] [Abstract][Full Text] [Related]
4. The neuronal chemokine CX3CL1/fractalkine selectively recruits NK cells that modify experimental autoimmune encephalomyelitis within the central nervous system.
Huang D; Shi FD; Jung S; Pien GC; Wang J; Salazar-Mather TP; He TT; Weaver JT; Ljunggren HG; Biron CA; Littman DR; Ransohoff RM
FASEB J; 2006 May; 20(7):896-905. PubMed ID: 16675847
[TBL] [Abstract][Full Text] [Related]
5. Infiltration of CCR2+Ly6Chigh Proinflammatory Monocytes and Neutrophils into the Central Nervous System Is Modulated by Nicotinic Acetylcholine Receptors in a Model of Multiple Sclerosis.
Jiang W; St-Pierre S; Roy P; Morley BJ; Hao J; Simard AR
J Immunol; 2016 Mar; 196(5):2095-108. PubMed ID: 26810225
[TBL] [Abstract][Full Text] [Related]
6. Monocytes and Monocyte-Derived Antigen-Presenting Cells Have Distinct Gene Signatures in Experimental Model of Multiple Sclerosis.
Monaghan KL; Zheng W; Hu G; Wan ECK
Front Immunol; 2019; 10():2779. PubMed ID: 31849962
[TBL] [Abstract][Full Text] [Related]
7. Spatio-temporal profile, phenotypic diversity, and fate of recruited monocytes into the post-ischemic brain.
Garcia-Bonilla L; Faraco G; Moore J; Murphy M; Racchumi G; Srinivasan J; Brea D; Iadecola C; Anrather J
J Neuroinflammation; 2016 Nov; 13(1):285. PubMed ID: 27814740
[TBL] [Abstract][Full Text] [Related]
8. The Cholinergic System Contributes to the Immunopathological Progression of Experimental Pulmonary Tuberculosis.
Islas-Weinstein L; Marquina-Castillo B; Mata-Espinosa D; Paredes-González IS; Chávez J; Balboa L; Marín Franco JL; Guerrero-Romero D; Barrios-Payan JA; Hernandez-Pando R
Front Immunol; 2020; 11():581911. PubMed ID: 33679685
[TBL] [Abstract][Full Text] [Related]
9. Physiological functions of the cholinergic system in immune cells.
Fujii T; Mashimo M; Moriwaki Y; Misawa H; Ono S; Horiguchi K; Kawashima K
J Pharmacol Sci; 2017 May; 134(1):1-21. PubMed ID: 28552584
[TBL] [Abstract][Full Text] [Related]
10. Temporal expression and cellular origin of CC chemokine receptors CCR1, CCR2 and CCR5 in the central nervous system: insight into mechanisms of MOG-induced EAE.
Eltayeb S; Berg AL; Lassmann H; Wallström E; Nilsson M; Olsson T; Ericsson-Dahlstrand A; Sunnemark D
J Neuroinflammation; 2007 May; 4():14. PubMed ID: 17484785
[TBL] [Abstract][Full Text] [Related]
11. Distinctive Roles for α7*- and α9*-Nicotinic Acetylcholine Receptors in Inflammatory and Autoimmune Responses in the Murine Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis.
Liu Q; Whiteaker P; Morley BJ; Shi FD; Lukas RJ
Front Cell Neurosci; 2017; 11():287. PubMed ID: 29018331
[TBL] [Abstract][Full Text] [Related]
12. Activation of invariant NKT cells in early phase of experimental autoimmune encephalomyelitis results in differentiation of Ly6Chi inflammatory monocyte to M2 macrophages and improved outcome.
Denney L; Kok WL; Cole SL; Sanderson S; McMichael AJ; Ho LP
J Immunol; 2012 Jul; 189(2):551-7. PubMed ID: 22685310
[TBL] [Abstract][Full Text] [Related]
13. CX3CR1-dependent recruitment of mature NK cells into the central nervous system contributes to control autoimmune neuroinflammation.
Hertwig L; Hamann I; Romero-Suarez S; Millward JM; Pietrek R; Chanvillard C; Stuis H; Pollok K; Ransohoff RM; Cardona AE; Infante-Duarte C
Eur J Immunol; 2016 Aug; 46(8):1984-96. PubMed ID: 27325505
[TBL] [Abstract][Full Text] [Related]
14. Erythropoietin reduces experimental autoimmune encephalomyelitis severity via neuroprotective mechanisms.
Moransard M; Bednar M; Frei K; Gassmann M; Ogunshola OO
J Neuroinflammation; 2017 Oct; 14(1):202. PubMed ID: 29029628
[TBL] [Abstract][Full Text] [Related]
15. Cholinergic control of Th17 cell pathogenicity in experimental autoimmune encephalomyelitis.
Nechanitzky R; Nechanitzky D; Ramachandran P; Duncan GS; Zheng C; Göbl C; Gill KT; Haight J; Wakeham AC; Snow BE; Bradaschia-Correa V; Ganguly M; Lu Z; Saunders ME; Flavell RA; Mak TW
Cell Death Differ; 2023 Feb; 30(2):407-416. PubMed ID: 36528755
[TBL] [Abstract][Full Text] [Related]
16. CCR2-dependent dendritic cell accumulation in the central nervous system during early effector experimental autoimmune encephalomyelitis is essential for effector T cell restimulation in situ and disease progression.
Clarkson BD; Walker A; Harris MG; Rayasam A; Sandor M; Fabry Z
J Immunol; 2015 Jan; 194(2):531-41. PubMed ID: 25505278
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of inflammatory cytokines parallels progression of central nervous system pathology in two clinically distinct models of multiple sclerosis.
Begolka WS; Vanderlugt CL; Rahbe SM; Miller SD
J Immunol; 1998 Oct; 161(8):4437-46. PubMed ID: 9780223
[TBL] [Abstract][Full Text] [Related]
18. Licensing of myeloid cells promotes central nervous system autoimmunity and is controlled by peroxisome proliferator-activated receptor γ.
Hucke S; Floßdorf J; Grützke B; Dunay IR; Frenzel K; Jungverdorben J; Linnartz B; Mack M; Peitz M; Brüstle O; Kurts C; Klockgether T; Neumann H; Prinz M; Wiendl H; Knolle P; Klotz L
Brain; 2012 May; 135(Pt 5):1586-605. PubMed ID: 22447120
[TBL] [Abstract][Full Text] [Related]
19. IL-1β enables CNS access to CCR2
Paré A; Mailhot B; Lévesque SA; Juzwik C; Ignatius Arokia Doss PM; Lécuyer MA; Prat A; Rangachari M; Fournier A; Lacroix S
Proc Natl Acad Sci U S A; 2018 Feb; 115(6):E1194-E1203. PubMed ID: 29358392
[TBL] [Abstract][Full Text] [Related]
20. Helminth Imprinting of Hematopoietic Stem Cells Sustains Anti-Inflammatory Trained Innate Immunity That Attenuates Autoimmune Disease.
Cunningham KT; Finlay CM; Mills KHG
J Immunol; 2021 Apr; 206(7):1618-1630. PubMed ID: 33579723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
